Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.

about

Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening.

P2860

Q37737468-C8BFAE92-8428-4339-AB75-FDB2BA3598D4 Q47150840-3D7A9B1D-2F82-428B-A71E-7A2EDCFB3F65

P2860

Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.

Item

http://www.wikidata.org/entity/Q35926547

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@ast

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@en

type

Item

label

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@ast

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@en

prefLabel

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@ast

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@en

P1476

Meeting individualized glycemi ...... with type 2 diabetes in Spain.

@en

P2093

A Pérez

http://www.w3.org/2001/XMLSchema#string

I Miñambres

http://www.w3.org/2001/XMLSchema#string

J J Mediavilla

http://www.w3.org/2001/XMLSchema#string

J Sarroca

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry.

Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).

Public health implications of recommendations to individualize glycemic targets in adults with diabetes.

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.

Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.

P2888

s12902-016-0090-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12902-016-0090-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295009860

http://www.w3.org/2001/XMLSchema#string

P6179

1002392056

http://www.w3.org/2001/XMLSchema#string

P698

26887662

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4756540

http://www.w3.org/2001/XMLSchema#string

Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.

about

P2860

P2860

Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P921

P932